Artwork

Sisällön tarjoaa Dr. Francavilla. Dr. Francavilla tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Player FM - Podcast-sovellus
Siirry offline-tilaan Player FM avulla!

Beyond Ozempic: The Future of Obesity Medicine with Dr. Mike Albert

36:03
 
Jaa
 

Manage episode 445173493 series 3415408
Sisällön tarjoaa Dr. Francavilla. Dr. Francavilla tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

Check out the Medical Weight Loss Summit, launching on October 15th, 2024, which I collaborated on with Dr. Talks!

Link: Medical Weight Loss Summit — Dr. Francavilla Show

What’s changing in the field of obesity medicine?

Keeping up with the changes in obesity medicine can be a bit tricky, which is why Dr. Mike Albert, a board-certified specialist in internal and obesity medicine and co-founder of Accomplish Health, is here to share his insights. Accomplish Health is a telehealth practice focused on providing comprehensive obesity care. When he's not working, Dr. Albert educates over 300,000 followers on social media about all things obesity.

In this episode, Dr. Albert dives into the latest advancements in obesity care, especially the rise of GLP-1 medications. These new treatments are shaking things up and offering more effective options, but with big companies getting involved, there’s concern about whether quality care is getting lost in the rush for profit. He points out that these hormone-based therapies use hormones from the gastrointestinal tract to help regulate appetite and energy, and they’re actually more potent than the hormones our bodies naturally produce — all thanks to some cool advances in biotechnology.

The discussion also covers how we’re shifting our view of obesity from just focusing on weight loss to recognizing it as a complex chronic disease with metabolic implications. It’s a big change that highlights the need for a more comprehensive approach to treatment.

If you’re curious about the latest trends and insights in obesity medicine, be sure to tune in to the latest episode.

Check out Calocurb:

Connect with me:

  continue reading

102 jaksoa

Artwork
iconJaa
 
Manage episode 445173493 series 3415408
Sisällön tarjoaa Dr. Francavilla. Dr. Francavilla tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

Check out the Medical Weight Loss Summit, launching on October 15th, 2024, which I collaborated on with Dr. Talks!

Link: Medical Weight Loss Summit — Dr. Francavilla Show

What’s changing in the field of obesity medicine?

Keeping up with the changes in obesity medicine can be a bit tricky, which is why Dr. Mike Albert, a board-certified specialist in internal and obesity medicine and co-founder of Accomplish Health, is here to share his insights. Accomplish Health is a telehealth practice focused on providing comprehensive obesity care. When he's not working, Dr. Albert educates over 300,000 followers on social media about all things obesity.

In this episode, Dr. Albert dives into the latest advancements in obesity care, especially the rise of GLP-1 medications. These new treatments are shaking things up and offering more effective options, but with big companies getting involved, there’s concern about whether quality care is getting lost in the rush for profit. He points out that these hormone-based therapies use hormones from the gastrointestinal tract to help regulate appetite and energy, and they’re actually more potent than the hormones our bodies naturally produce — all thanks to some cool advances in biotechnology.

The discussion also covers how we’re shifting our view of obesity from just focusing on weight loss to recognizing it as a complex chronic disease with metabolic implications. It’s a big change that highlights the need for a more comprehensive approach to treatment.

If you’re curious about the latest trends and insights in obesity medicine, be sure to tune in to the latest episode.

Check out Calocurb:

Connect with me:

  continue reading

102 jaksoa

Kaikki jaksot

×
 
Loading …

Tervetuloa Player FM:n!

Player FM skannaa verkkoa löytääkseen korkealaatuisia podcasteja, joista voit nauttia juuri nyt. Se on paras podcast-sovellus ja toimii Androidilla, iPhonela, ja verkossa. Rekisteröidy sykronoidaksesi tilaukset laitteiden välillä.

 

Pikakäyttöopas